Montanide ISA51

BIOLOGICAL2 trials

Sponsors

Masonic Cancer Center, University of Minnesota, Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Conditions

CancerMelanoma

Phase 1

Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

TerminatedNCT00365937

Cliniques universitaires Saint-Luc- Université Catholique de LouvainMelanoma

Start: 2006-08-31End: 2013-12-13Updated: 2019-03-06

Unknown Phase

Vaccination With Tetanus and KLH to Assess Immune Responses.

TerminatedNCT00000105

Masonic Cancer Center, University of MinnesotaCancer

Start: 2002-07-31End: 2012-03-31Updated: 2017-11-29